
NanJing Pharmaceutical Company Limited
SSE:600713.SS
5.19 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 53,696.174 | 53,589.665 | 50,221.564 | 45,123.195 | 39,817.364 | 37,155.742 | 31,303.046 | 27,473.449 | 26,720.501 | 24,813.087 | 22,075.781 | 18,737.79 | 18,024.22 | 17,171.694 | 15,337.627 | 14,025.514 | 11,396.288 | 9,344.858 | 6,827.704 | 6,229.685 | 5,259.718 | 4,217.425 | 2,068.69 | 1,428.644 | 1,329.201 | 1,146.28 | 879.497 | 582.339 | 502.805 | 489.879 | 406.031 | 454.988 |
Cost of Revenue
| 50,323.078 | 50,282.61 | 46,962.43 | 42,185.985 | 37,286.15 | 34,698.92 | 29,235.117 | 25,734.523 | 25,149.007 | 23,344.121 | 20,738.035 | 17,543.503 | 16,660.839 | 15,962.527 | 14,248.339 | 13,111.002 | 10,564.206 | 8,656.116 | 6,349.771 | 5,777.717 | 4,830.175 | 3,798.52 | 1,805.052 | 1,198.198 | 1,110.04 | 959.433 | 715.01 | 459.57 | 412.18 | 405.867 | 338.711 | 394.784 |
Gross Profit
| 3,373.096 | 3,307.055 | 3,259.134 | 2,937.21 | 2,531.214 | 2,456.823 | 2,067.929 | 1,738.926 | 1,571.494 | 1,468.967 | 1,337.746 | 1,194.288 | 1,363.381 | 1,209.167 | 1,089.288 | 914.513 | 832.082 | 688.742 | 477.933 | 451.968 | 429.543 | 418.905 | 263.638 | 230.446 | 219.16 | 186.847 | 164.487 | 122.769 | 90.625 | 84.012 | 67.32 | 60.204 |
Gross Profit Ratio
| 0.063 | 0.062 | 0.065 | 0.065 | 0.064 | 0.066 | 0.066 | 0.063 | 0.059 | 0.059 | 0.061 | 0.064 | 0.076 | 0.07 | 0.071 | 0.065 | 0.073 | 0.074 | 0.07 | 0.073 | 0.082 | 0.099 | 0.127 | 0.161 | 0.165 | 0.163 | 0.187 | 0.211 | 0.18 | 0.171 | 0.166 | 0.132 |
Reseach & Development Expenses
| 30.635 | 36.189 | 27.434 | 20.958 | 15.999 | 13.351 | 6.434 | 1.7 | 6.048 | 1.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 127.138 | 135.301 | 77.519 | 53.667 | 54.2 | 60.104 | 62.693 | 55.669 | 65.012 | 58.468 | 108.135 | 118.914 | 186.204 | 182.357 | 136.783 | 322.804 | 296.517 | 262.535 | 245.488 | 239.369 | 229.157 | 196.243 | 131.566 | 107.271 | 86.976 | 51.679 | 57.888 | 43.307 | 36.295 | 30.107 | 22.667 | 10.542 |
Selling & Marketing Expenses
| 461.495 | 459.527 | 1,157.584 | 1,076.071 | 953.444 | 976.561 | 824.149 | 692.216 | 575.341 | 516.507 | 474.928 | 476.545 | 562.582 | 549.289 | 458.165 | 401.373 | 369.493 | 282.539 | 181.426 | 166.01 | 160.205 | 150.5 | 81.454 | 86.931 | 72.075 | 48.231 | 31.814 | 29.787 | 17.334 | 13.731 | 12.402 | 11.966 |
SG&A
| 588.632 | 1,674.485 | 1,235.103 | 1,129.738 | 1,007.644 | 1,036.664 | 886.842 | 747.886 | 640.353 | 574.975 | 583.064 | 595.459 | 748.786 | 731.646 | 594.948 | 724.177 | 666.01 | 545.074 | 426.914 | 405.379 | 389.362 | 346.743 | 213.02 | 194.203 | 159.051 | 99.91 | 89.702 | 73.094 | 53.629 | 43.838 | 35.069 | 22.508 |
Other Expenses
| 1,730.425 | 588.938 | 497.323 | 455.161 | 389.277 | 402.387 | -3.936 | -20.926 | -6.762 | 15.613 | 25.731 | 20.541 | 98.826 | 13.8 | 48.544 | 34.848 | 12.999 | 27.145 | 41.058 | 25.047 | 17.45 | 8.727 | 3.361 | 4.262 | 3.471 | 1.447 | 0.209 | 2.769 | 4.494 | -0.059 | -0.785 | 0.012 |
Operating Expenses
| 2,349.692 | 2,299.612 | 1,759.86 | 1,605.857 | 1,412.919 | 1,452.403 | 1,260.555 | 1,053.209 | 981.209 | 946.55 | 900.135 | 908.292 | 1,085.759 | 1,094.588 | 884.726 | 743.127 | 682.119 | 557.272 | 435.741 | 413.645 | 396.794 | 354.282 | 218.744 | 198.657 | 163.487 | 103.758 | 93.121 | 75.387 | 55.504 | 46.105 | 35.672 | 29.874 |
Operating Income
| 1,023.404 | 1,007.443 | 1,320.05 | 1,233.922 | 1,037.233 | 1,068.734 | 479.732 | 460.908 | 346.847 | 258.995 | 180.486 | 107.498 | -40.083 | -162.206 | -11.782 | 59.458 | 51.825 | 96.34 | 18.774 | 29.571 | 16.85 | 48.569 | 47.399 | 55.907 | 67.699 | 90.917 | 73.186 | 45.619 | 32.222 | 26.722 | 21.258 | 11.551 |
Operating Income Ratio
| 0.019 | 0.019 | 0.026 | 0.027 | 0.026 | 0.029 | 0.015 | 0.017 | 0.013 | 0.01 | 0.008 | 0.006 | -0.002 | -0.009 | -0.001 | 0.004 | 0.005 | 0.01 | 0.003 | 0.005 | 0.003 | 0.012 | 0.023 | 0.039 | 0.051 | 0.079 | 0.083 | 0.078 | 0.064 | 0.055 | 0.052 | 0.025 |
Total Other Income Expenses Net
| -20.009 | -29.375 | -413.519 | -6.847 | 1.538 | 60.147 | -3.936 | -56.084 | -7.176 | 12.108 | 23.539 | 13.448 | -219.801 | -182.443 | -124.045 | 33.546 | -85.409 | 27.145 | 16.007 | 7.31 | 4.484 | 2.4 | -1.597 | -1.292 | -6.512 | -1.584 | -1.022 | -0.696 | 3.294 | -0.643 | -0.785 | 0.012 |
Income Before Tax
| 1,003.395 | 978.068 | 906.012 | 838.866 | 677.799 | 588.87 | 475.796 | 439.982 | 339.786 | 271.103 | 204.025 | 121.235 | 57.821 | -149.99 | 36.173 | 93.998 | 64.555 | 123.485 | 35.014 | 36.88 | 21.335 | 50.969 | 45.802 | 54.614 | 66.099 | 88.503 | 72.164 | 44.924 | 35.516 | 26.079 | 20.474 | 11.563 |
Income Before Tax Ratio
| 0.019 | 0.018 | 0.018 | 0.019 | 0.017 | 0.016 | 0.015 | 0.016 | 0.013 | 0.011 | 0.009 | 0.006 | 0.003 | -0.009 | 0.002 | 0.007 | 0.006 | 0.013 | 0.005 | 0.006 | 0.004 | 0.012 | 0.022 | 0.038 | 0.05 | 0.077 | 0.082 | 0.077 | 0.071 | 0.053 | 0.05 | 0.025 |
Income Tax Expense
| 260.275 | 265.259 | 190.092 | 228.314 | 207.761 | 157.32 | 129.964 | 128.73 | 101.192 | 78.416 | 51.611 | 61.416 | 62.992 | 33.474 | 42.492 | 39.019 | 20.401 | 52.143 | 10.736 | 9.443 | 9.704 | 15.893 | 9.984 | 13.665 | 13.105 | 12.809 | 11.725 | 6.816 | 5.294 | 8.822 | 6.803 | 3.3 |
Net Income
| 570.628 | 577.826 | 595.668 | 505.183 | 376.413 | 346.92 | 264.294 | 239.271 | 180.272 | 156.724 | 128.88 | 38.681 | 10.82 | -182.617 | 9.374 | 46.242 | 30.335 | 46.68 | 18.584 | 18.354 | 2.402 | 20.538 | 28.198 | 36.898 | 48.527 | 74.015 | 59.414 | 38.107 | 30.222 | 17.257 | 13.671 | 8.263 |
Net Income Ratio
| 0.011 | 0.011 | 0.012 | 0.011 | 0.009 | 0.009 | 0.008 | 0.009 | 0.007 | 0.006 | 0.006 | 0.002 | 0.001 | -0.011 | 0.001 | 0.003 | 0.003 | 0.005 | 0.003 | 0.003 | 0 | 0.005 | 0.014 | 0.026 | 0.037 | 0.065 | 0.068 | 0.065 | 0.06 | 0.035 | 0.034 | 0.018 |
EPS
| 0.44 | 0.45 | 0.48 | 0.49 | 0.36 | 0.33 | 0.26 | 0.26 | 0.2 | 0.18 | 0.18 | 0.056 | 0.016 | -0.26 | 0.014 | 0.082 | 0.061 | 0.078 | 0.018 | 0.039 | 0.005 | 0.044 | 0.061 | 0.072 | 0.085 | 0.16 | 0.12 | 0.11 | 0.084 | 0.042 | 0.034 | 0.02 |
EPS Diluted
| 0.44 | 0.45 | 0.48 | 0.49 | 0.36 | 0.33 | 0.26 | 0.26 | 0.2 | 0.18 | 0.18 | 0.056 | 0.016 | -0.26 | 0.014 | 0.082 | 0.061 | 0.078 | 0.018 | 0.039 | 0.005 | 0.044 | 0.061 | 0.072 | 0.085 | 0.16 | 0.12 | 0.11 | 0.084 | 0.042 | 0.034 | 0.02 |
EBITDA
| 1,591.412 | 1,619.329 | 1,622.942 | 1,548.011 | 1,165.836 | 1,193.678 | 966.502 | 753.886 | 641.05 | 362.545 | 593.576 | 472.877 | 486.126 | 246.602 | 291.996 | 284.458 | 251.744 | 260.914 | 138.3 | 132.164 | 103.466 | 119.856 | 84.249 | 80.723 | 90.682 | 95.569 | 78.285 | 47.382 | 35.121 | 37.907 | 31.648 | 30.33 |
EBITDA Ratio
| 0.03 | 0.03 | 0.032 | 0.034 | 0.029 | 0.032 | 0.031 | 0.027 | 0.024 | 0.015 | 0.027 | 0.025 | 0.027 | 0.014 | 0.019 | 0.02 | 0.022 | 0.028 | 0.02 | 0.021 | 0.02 | 0.028 | 0.041 | 0.057 | 0.068 | 0.083 | 0.089 | 0.081 | 0.07 | 0.077 | 0.078 | 0.067 |